This episode of The Nordic Venture Show podcast features Freya Biosciences, a clinical-stage biotech company focused on developing microbial immunotherapies to address women's reproductive health issues. Their primary focus is on conditions linked to vaginal dysbiosis, such as infertility related to IVF and endometriosis, as well as preterm birth. The company highlights its ongoing clinical trials, completed proof-of-concept studies, partnerships with key opinion leaders and institutions like Boston IVF, and recent funding rounds, demonstrating their progress in this under-addressed area of women's health.